Magnetic Resonance Imaging
Volume 28, Issue 3 , Pages 314-319 , April 2010

Quantitative multivoxel proton chemical shift imaging of the breast

Received 9 September 2009 ,Accepted 26 November 2009.

References 

  1. Sijens PE, Wijrdeman HK, Moerland MA, Bakker CJG, Vermeulen JWAH, Luyten PR. Human breast cancer in vivo: 1H & 31P MR spectroscopy at 1.5T. Radiology. 1988;169:615–620
  2. Gribbestad IS, Singstad TE, Nilsen G, Fjøsne HE, Engan T, Haugen AO, et al. In vivo 1H MRS of normal breast and breast tumors using a dedicated double breast coil. J Magn Reson Imaging. 1998;8:1191–1197
  3. Roebock JR, Cecil KM, Schnall MD, Linkenski RE. Human breast lesions: characterization with proton MR spectroscopy. Radiology. 1998;209:269–275
  4. Young DKW, Cheung HS, Tse CMK. Human breast lesions: characterization with contrast-enhanced in vivo proton MR spectroscopy — initial results. Radiology. 2001;220:40–46
  5. Cecil KM, Schnall MD, Siegelman ES, Lenkinski RE. The evaluation of human breast lesions with magnetic resonance imaging and proton magnetic resonance spectroscopy. Breast Cancer Res Treat. 2001;68:45–54
  6. Jagannathan NR, Kumar M, Seenu MK, Coshic O, Dwivedi SN, Julka PK, et al. Evaluation of total choline from in-vivo volume localized spectroscopy and its response to neoadjuvant chemotherapy in locally advance breast cancer. Br J Cancer. 2001;84:1016–1022
  7. Bolan PJ, Meisamy S, Baker EH, Lin J, Emory T, Nelson M, et al. In vivo quantification of choline compounds in the breast with 1H MR spectroscopy. Magn Reson Med. 2003;50:1134–1143
  8. Huang W, Fischer PR, Dulaimy K, Tudorica LA, O'Hea B, Button TM. Detection of breast malignancy: diagnostic MR protocol for improved specificity. Radiology. 2004;232:585–591
  9. Lee J, Yamaguchi T, Abe A, Shizukuishi K, Uemura H, Miyagi E, et al. Clinical evaluation of choline measurement by proton MR spectroscopy in patients with malignant tumors. Radiat Med. 2004;22:148–154
  10. Joe BN, Chen VY, Salibi N, Fuangtharntip P, Hildeboldt CF, Bae KT. Evaluation of 1H-magnetic resonance spectroscopy of breast cancer pre- and postgadolinium administration. Invest Radiol. 2005;40:405–411
  11. Stanwell P, Gluch L, Clark D, Tomanek B, Baker L, Giuffrè B, et al. Specificity of choline metabolites for in vivo diagnosis of breast cancer using 1H MRS at 1.5T. Eur Radiol. 2005;15:1037–1043
  12. Baik HM, Su MY, Yu H, Mehta R, Nalcioglu O. Quantification of choline-containing compounds in malignant breast tumors by 1H MR spectroscopy using water as an internal reference at 1.5 T. MAGMA. 2006;19:96–104
  13. Bartella L, Morris EA, Dershaw DD, Liberman L, Thakur SB, Moskowitz C, et al. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis. Radiology. 2006;239:686–692
  14. Bartella L, Thakur SB, Morris EA, Dershaw DD, Huang W, Chough E, et al. Enhancing non-mass lesions in the breast: evaluation with proton MR spectroscopy. Radiology. 2007;245:80–87
  15. Geraghty PR, van den Bosch MAAJ, Spielman DM, Hunjan S, Birdwell RL, Fong KJ, et al. MRI and 1H MRS of the breast: presence of a choline peak as malignancy marker is related to k21 value of the tumor in patients with invasive ductal carcinoma. Breast J. 2008;14:574–580
  16. Baek HM, Chen JH, Nalcioglu O, Su MY. Proton MR spectroscopy for monitoring early treatment response of breast cancer to neo-adjuvant chemotherapy. Annals Oncol. 2008;19:1022–1024
  17. Jacobs MA, Barker PB, Argani P, Ouwerkerk R, Bhujwalla ZM, Bluemke DA. Combined dynamic contrast enhanced breast MR and proton spectroscopic imaging: a feasibility study. J Magn Reson Imaging. 2005;21:23–28
  18. Su MY, Baik HM, Yu HJ, Chen JM, Mehta RS, Nalcioglu O. Comparison of choline and pharmacokinetic parameters in breast cancer measured by MR spectroscopic imaging and dynamic contrast enhanced MRI. Technol Cancer Res Treat. 2006;5:401–410
  19. Stanwell P, Mountford C. In vivo proton MR spectroscopy of the breast. Radiographics. 2007;27:S253–S266
  20. Baek HM, Chen JH, Yu HJ, Mehta R, Nalcioglu O, Su MY. Detection of choline signal in human breast lesions with chemical shift imaging. J Magn Reson Imaging. 2008;27:1114–1121
  21. Bottomley PA. Spatial localization in NMR spectroscopy in vivo. Ann NY Acad Sci. 1987;508:333–348
  22. Ordidge RJ, Mansfield P, Lohman JA, Prime SB. Volume selection using gradients and selective pulses. Ann NY Acad Sci. 1987;508:376–385
  23. Mao J, Mareci TH, Andrew ER. Experimental study of optimal selective 180° radiofrequency pulses. J Magn Reson. 1988;79:1–10
  24. Mescher M, Tannus A, O'Neil Johnson M, Garwood M. Solvent suppression using selective echo dephasing. J Magn Reson A. 1996;123:226–229
  25. Star-Lack J, Nelson SJ, Kurhanewicz J, Huang LR, Vigneron DB. Improved water and lipid suppression for 3D PRESS CSI using RF band selective inversion with gradient dephasing (BASING). Magn Reson Med. 1997;38:311–321
  26. Ogg RJ, Kingsley PB, Taylor JS. WET, a T1- and B1-insensitive water-suppression method for in vivo localized spectroscopy. J Magn Reson B. 1994;104:1–10
  27. Irwan R, Edens MA, Sijens PE. Assessment of the variations in fat content in normal liver using a fast quantitative MR imaging method in comparison with results obtained by spectroscopic imaging. Eur Radiol. 2008;18:806–813
  28. Chen JH, Avram HE, Crooks LE, Arakawa M, Kaufman L, Brito AC. In vivo relaxation times and hydrogen density at 0.063–4.85 T in rats with implanted mammary adenocarcinomas. Radiology. 1992;184:427–434
  29. Graham SJ, Ness S, Hamilton BS, Bronskill MJ. Magnetic resonance properties of ex vivo breast tissue at 1.5 T. Magn Reson Med. 1997;38:669–677
  30. Rakow-Penner R, Daniel B, Yu H, Sawyer-Glover A, Glover GH. Relaxation times of breast tissue at 1.5 T and 3 T measured using IDEAL. J Magn Reson Imaging. 2006;23:87–91
  31. Sijens PE, Oudkerk M. 1H Chemical shift imaging characterization of human brain tumor and edema. Eur Radiol. 2002;12:2056–2061
  32. Bakken IJ, Gribbestad IS, Singstad TE, Kvistad KA. External standard method for the in vivo quantification of choline containing compounds in breast tumors by proton MR spectroscopy at 1.5 tesla. Magn Reson Med. 2001;46:189–192
  33. Sijens PE, Oudkerk M. Clinical magnetic resonance spectroscopy. Imaging Decis MRI. 2005;9:39–48
  34. Sijens PE, Levendag PC, Vecht CHJ, van Dijk P, Oudkerk M. 1H MR spectroscopy detection of lipids and lactate in metastatic brain tumors. NMR Biomed. 1996;9:65–71
  35. Sijens PE, Mostert JP, Oudkerk M, De Keyser J. 1H MR spectroscopy of the brain in multiple sclerosis subtypes with analysis of the metabolite concentrations in gray and white matter: initial findings. Eur Radiol. 2006;16:489–495
  36. Tan PC, Pickles MD, Lowry M, Manton DJ, Turnbull LW. Lesion T2 relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapy. Magn Reson Imaging. 2008;26:26–34

PII: S0730-725X(09)00282-3

doi: 10.1016/j.mri.2009.11.004

Magnetic Resonance Imaging
Volume 28, Issue 3 , Pages 314-319 , April 2010

Article Tools

* Image Usage & Resolution